Medications

Skyrizi approved for psoriatic arthritis

(HealthDay)—The U.S. Food and Drug Administration has expanded the approval of Skyrizi (risankizumab-rzaa) to treatment of adults with active psoriatic arthritis, the manufacturer announced Friday.

Arthritis & Rheumatism

Arthritis & the COVID vaccine: What you need to know

(HealthDay)—Some arthritis drugs may reduce the effectiveness of COVID vaccines, according to the Arthritis Foundation, which also offers advice on booster shots.

Diseases, Conditions, Syndromes

What is Hashimoto's disease?

January is Thyroid Awareness Month, which makes this a good time to learn more about Hashimoto's disease.

Arthritis & Rheumatism

Two-thirds of adults with arthritis engage in physical activity

(HealthDay)—About two-thirds of adults with arthritis report engaging in physical activity, with walking the most commonly reported activity, according to research published in the Oct. 8 issue of the U.S. Centers for Disease ...

Arthritis & Rheumatism

Poverty tied to worse functional status in rheumatoid arthritis

(HealthDay)—Worse functional status and increased probability of functional decline are seen for patients with rheumatoid arthritis (RA) with lower socioeconomic status (SES), according to a study published online Aug. ...

Diseases, Conditions, Syndromes

Arthritis drug shows promise against severe COVID: study

A repurposed arthritis drug has shown positive results in a clinical trial of patients hospitalized with COVID-19, according to a paper published Wednesday in the New England Journal of Medicine.

page 3 from 25